nelfinavir has been researched along with Diarrhea in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 12 (70.59) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Black, FT; Jensen-Fangel, S; Justesen, US; Obel, N; Pedersen, C | 1 |
| Alper, SL; Andrade, A; Flexner, C; Jiang, L; Lencer, WI; Lin, PW; Rameh, L; Rufo, PA | 1 |
| DeSilva, KE; Guest, JL; Rimland, D; Ruffin, C; Tschampa, JM | 1 |
| Arasteh, K; Artigas, JG; Clotet, B; Danise, A; Foreman, R; Gonzalez-Garcia, J; Horban, A; Johnson, M; Landman, R; Nieto-Cisneros, L; Proll, S; Smith, P; Snowden, W | 1 |
| Garner, RC; Hsyu, PH; Lappin, G; Sarapa, N | 1 |
| Crownover, PH; Damle, BD; Fang, AF; Glue, PW; Hewlett, D; LaBadie, RR | 1 |
| Hart, AA; Hoetelmans, RM; Lange, JM; Mulder, JW; Reijers, MH; Reiss, P; Schuitemaker, H; Ten Kate, RW; Weigel, HM; Weverling, GJ | 1 |
| Ryan, A | 1 |
| Bode, H; Fromm, M; Riecken, EO; Schmidt, W; Schulzke, JD; Ullrich, R | 1 |
| Fornataro, K; Jefferys, R | 1 |
| Baede-van Dijk, PA; Burger, DM; Hekster, YA; Hugen, PW; Koopmans, PP; Verweij-van Wissen, CP | 1 |
| Gartland, M | 1 |
7 trial(s) available for nelfinavir and Diarrhea
| Article | Year |
|---|---|
The use of calcium carbonate in nelfinavir-associated diarrhoea in HIV-1-infected patients.
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Calcium Carbonate; Calcium Gluconate; Chronic Disease; Diarrhea; Drug Combinations; Drug Interactions; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Nelfinavir; Pilot Projects; Prospective Studies; Severity of Illness Index | 2003 |
Comparison of gastrointestinal tolerability and patient preference for treatment with the 625 mg and 250 mg nelfinavir tablet formulations.
Topics: CD4 Lymphocyte Count; Diarrhea; Drug Administration Schedule; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Nelfinavir; Patient Satisfaction; Tablets; Viral Load | 2005 |
The application of accelerator mass spectrometry to absolute bioavailability studies in humans: simultaneous administration of an intravenous microdose of 14C-nelfinavir mesylate solution and oral nelfinavir to healthy volunteers.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Biological Availability; Carbon Radioisotopes; Diarrhea; HIV Protease Inhibitors; Humans; Infusions, Intravenous; Male; Mass Spectrometry; Metabolic Clearance Rate; Middle Aged; Nelfinavir; Reproducibility of Results; Time Factors | 2005 |
Significant decrease in nelfinavir systemic exposure after omeprazole coadministration in healthy subjects.
Topics: Adolescent; Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diarrhea; Dizziness; Drug Interactions; Female; Gastric Juice; Headache; HIV Protease Inhibitors; Humans; Hydrogen-Ion Concentration; Male; Metabolic Clearance Rate; Middle Aged; Mixed Function Oxygenases; Nelfinavir; Omeprazole; Proton Pump Inhibitors; Syncope; Tablets | 2008 |
Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Diarrhea; Drug Therapy, Combination; Female; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Liver; Male; Middle Aged; Nausea; Nelfinavir; Reverse Transcriptase Inhibitors; Saquinavir; Stavudine | 2000 |
Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients.
Topics: Adolescent; Adult; Age Factors; Aged; Aryl Hydrocarbon Hydroxylases; Body Weight; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Databases, Factual; Diarrhea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Induction; Enzyme Inhibitors; Female; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; Humans; Male; Middle Aged; Mixed Function Oxygenases; Nelfinavir; Omeprazole | 2001 |
AVANTI 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Clinical Protocols; Diarrhea; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Male; Nausea; Nelfinavir; Patient Compliance; RNA, Viral; Zidovudine | 2001 |
10 other study(ies) available for nelfinavir and Diarrhea
| Article | Year |
|---|---|
Supplement fix for nelfinavir-related diarrhea.
Topics: Diarrhea; Dietary Fiber; HIV Infections; HIV Protease Inhibitors; Humans; Nelfinavir; Probiotics | 2002 |
Diarrhea-associated HIV-1 APIs potentiate muscarinic activation of Cl- secretion by T84 cells via prolongation of cytosolic Ca2+ signaling.
Topics: Adult; Aspartic Acid Endopeptidases; Calcium Signaling; Carbachol; Cell Line; Cell Membrane; Chlorides; Cytosol; Diarrhea; Drug Synergism; Electric Conductivity; HIV Infections; HIV-1; Humans; Intestinal Mucosa; Intracellular Membranes; Middle Aged; Muscarinic Agonists; Nelfinavir; Protease Inhibitors; Time Factors | 2004 |
Differences in rates of diarrhea in patients with human immunodeficiency virus receiving lopinavir-ritonavir or nelfinavir.
Topics: Adult; Anti-Retroviral Agents; Antidiarrheals; Antiretroviral Therapy, Highly Active; Cohort Studies; Diarrhea; Georgia; HIV Infections; Humans; Incidence; Lopinavir; Middle Aged; Nelfinavir; Pyrimidinones; Retrospective Studies; Ritonavir; United States; United States Department of Veterans Affairs | 2004 |
Drugs for HIV infection.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Delavirdine; Diarrhea; Didanosine; Drug Interactions; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Nevirapine; Protease Inhibitors; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Virus Replication; Zalcitabine; Zidovudine | 1997 |
Calcium may help with diarrhea.
Topics: Calcium; Diarrhea; HIV Protease Inhibitors; Humans; Nelfinavir; Severity of Illness Index; Treatment Outcome | 1999 |
Pancrelipase for treatment-refractory diarrhea associated with nelfinavir.
Topics: Adult; Diarrhea; Gastrointestinal Agents; HIV Protease Inhibitors; Humans; Male; Nelfinavir; Pancrelipase; Treatment Outcome | 2000 |
Effects of HIV protease inhibitors on barrier function in the human intestinal cell line HT-29/B6.
Topics: Acquired Immunodeficiency Syndrome; Colon; Diarrhea; HIV Protease Inhibitors; HT29 Cells; Humans; Indinavir; Intestinal Absorption; Intestinal Mucosa; Nelfinavir; Ritonavir; Saquinavir | 2000 |
New drug approved to treat HIV.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4 Lymphocyte Count; Child; Clinical Trials as Topic; Diarrhea; Drug Approval; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Nelfinavir; Sulfonic Acids; United States; United States Food and Drug Administration; Viral Load | 1997 |
Ultrase and Viracept.
Topics: Clinical Trials as Topic; Diarrhea; Drug Interactions; Enzyme Therapy; HIV Infections; HIV Protease Inhibitors; Humans; Nelfinavir; New York City; Pancreas; Washington | 1999 |
Twice-daily dosing of Nelfinavir approved.
Topics: Diarrhea; HIV Infections; HIV Protease Inhibitors; Humans; Nelfinavir | 1999 |